Search this Section

HOME Core Outcome Set

Core Outcome Set (COS) and core outcome instruments (for clinical trials)

Clinical signs: Eczema Area and Severity Index (EASI)
Patient-reported symptoms: Patient-oriented Eczema Measure (POEM) and NRS-11 for peak itch over past 24 hours)
Long term control: (Recap of Atopic Eczema (RECAP) or Atopic Dermatitis Control Tool (ADCT)
Quality of Life: DLQI (adults), CDLQI (children), IDQoL (infants).

Get involved

Join us Follow usAnyone with an interest in atopic eczema outcomes can join HOME. We have 345 members worldwide.

Joint chairs of HOME

Eric Simpson, USA

Christian Apfelbacher, Germany

Hywel talks about the Core Outcome sets

When referencing the HOME core outcome set, please cite this paper:

The HOME Core outcome set for clinical trials of atopic dermatitis
Hywel C Williams, Jochen Schmitt, Kim S Thomas, Phyllis Spuls, Eric L Simpson, Christian J Apfelbacher, Joanne R Chalmers, Masutaka Furue, Norito Katoh, Louise A Gerbens, Yael A Leshem, Laura Howells, Jasvinder A Singh, Maarten Boars, HOME initiative
J Allergy Clin Immunol. 2022 Jun;149(6):1899-1911. doi: 10.1016\j.jaci.2022.03.017 EPub 2022 Mar 26